GM Advisory Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,057
| Closed | -$116K | – | 204 |
|
|
2021
Q4 | $116K | Buy |
19,057
+7,290
| +62% | +$44.4K | 0.01% | 195 |
|
|
2021
Q3 | $115K | Buy |
11,767
+455
| +4% | +$4.45K | 0.01% | 194 |
|
|
2021
Q2 | $162K | Buy |
11,312
+1,630
| +17% | +$23.3K | 0.02% | 197 |
|
|
2021
Q1 | $230K | Sell |
9,682
-2,475
| -20% | -$58.8K | 0.03% | 176 |
|
|
2020
Q4 | $162K | Sell |
12,157
-4,270
| -26% | -$56.9K | 0.02% | 171 |
|
|
2020
Q3 | $114K | Buy |
16,427
+1,087
| +7% | +$7.54K | 0.02% | 160 |
|
|
2020
Q2 | $188K | Buy |
15,340
+4,650
| +43% | +$57K | 0.03% | 165 |
|
|
2020
Q1 | $31K | Buy |
+10,690
| New | +$31K | 0.01% | 125 |
|